ProfileGDS5678 / 1451108_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 77% 78% 74% 78% 76% 78% 78% 78% 76% 78% 79% 77% 76% 77% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.1574777
GSM967853U87-EV human glioblastoma xenograft - Control 25.4723778
GSM967854U87-EV human glioblastoma xenograft - Control 34.8212474
GSM967855U87-EV human glioblastoma xenograft - Control 45.5181778
GSM967856U87-EV human glioblastoma xenograft - Control 55.0817476
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.2454478
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.2081978
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.4146678
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.0752176
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.467478
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 25.4890979
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.2151477
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.041276
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.1913377